Qonita Kurnia Anjani is a Doctor of Pharmacy at the School of Pharmacy, Queen’s University Belfast, Belfast, UK. She completed her Ph.D. studies in Pharmaceutical Sciences at Queen’s University Belfast, Belfast, UK, and has been awarded Awards and Honors. Her interests include drug delivery systems; extracellular fluids; drug formulation; pharmaceutical development; pharmaceutical analysis; and Pharmaceutics.
Ryan F. Donnelly graduated with a BSc (1st Class) in Pharmacy from Queen's University Belfast in 1999. Following a year of Pre-Registration training spent in Community Pharmacy, he returned to the School of Pharmacy to undertake a PhD in Pharmaceutics. He graduated in 2003 and, after a short period of post-doctoral research, was appointed to a Lectureship in Pharmaceutics in January 2004. He was promoted to Senior Lecturer in 2009, Reader in 2011, and, in 2013, to Chair in Pharmaceutical Technology. His research is centered on the design and physicochemical characterization of advanced polymeric drug delivery systems for transdermal and topical drug delivery, with a strong emphasis on improving therapeutic outcomes for patients. His bioadhesive patch design was used in successful photodynamic therapy of over 100 patients with neoplastic and dysplastic gynecological conditions and the patent was subsequently out-licensed. Currently, his research is focused on novel polymeric microneedle arrays for transdermal administration of "difficult-to-deliver" drugs and intradermal delivery of vaccines and photosensitizers. He has authored over 600 peer-reviewed publications, including several granted patents, six textbooks, and approximately 260 full papers.
Delly Ramadan graduated with a master's degree in pharmaceutical sciences from the Universitas Indonesia in 2015. He was selected as a permanent lecturer at the Laboratory of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Indonesia in 2016. He started his PhD program in 2017 and completed his PhD studies in Pharmacy at Queen's University Belfast in 2020. Currently, his research is focused on pharmaceutical technology, particularly transdermal drug delivery systems. He has been working on the development of polymeric microneedles for delivering both small and macromolecules. He has also been awarded Awards and Honors. His research interests include pharmaceutics; pharmaceutical technology; drug delivery systems; microneedles; and transdermal and intradermal delivery.
